Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07044232 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NICardipine for Fast Achievement of Systolic BP Targets in ICH

Study acronym: NICFAST
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 24, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Dec 31, 2025 to Sep 30, 2026 · Study sites: 0 to 1 · Completion date: Dec 31, 2027 to Sep 30, 2027 · 2 morev2 Show 5 more changesShow less
    • Primary completion date: Dec 31, 2025 to Sep 30, 2026
    • Study sites: 0 to 1
    • Completion date: Dec 31, 2027 to Sep 30, 2027
    • Eligibility criteria revised
    • Secondary endpoints: 11 to 14

    See this version in full on ClinicalTrials.gov ↗

  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Quality improvement study with a quasi-randomized design. The study monitors the effect of a gradually implemented treatment algorithm prioritizing intravenous antihypertensives (e.g., nicardipine) over long-acting nitrate patches. It aims to increase the proportion of patients reaching target systolic BP \<140 mmHg within 1 hour of hospital admission while monitoring safety, clinical outcomes, and healthcare resource utilization.
Trial Details
NCT Number NCT07044232
Lead Sponsor Aarhus University Hospital
Conditions Intracerebral Haemorrhage
Enrollment 88 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov